 |
 |
|
|
|
|||
|
|||
 |
|||
COM prof finds “lost” Cassavetes
film
Ray Carney, a COM professor in the department of film and television and
a renowned biographer of filmmaker John Cassavetes, has been credited
with discovering a lost version of Cassavetes’ 1968 film Faces at
the Library of Congress film archives. Carney noticed that the library’s
online catalogue of archived films listed one copy of Faces -- the first
noncommercial movie to win a large American audience and which was nominated
for three Academy Awards -- as 18 minutes longer than the other versions.
Although told it was probably a clerical error, he viewed the print and
“realized within seconds that I was not looking at a cataloguer’s
error,” says Carney, who has written five books on Cassavetes and
maintains a Web site devoted to him (www.cassavetes.com). “The evidence
from the credits alone was so conclusive, and I was so excited, that I
stopped the film before the first scene had appeared on the screen and
told [library staffers] what they had sitting in storage unknown to them
for so many years, waiting to be discovered.” Carney says that the
film went through at least five completely different assemblies, but it
had been believed that Cassavetes destroyed all of the alternative versions
after making the final release print. Carney’s most recent book,
Cassavetes on Cassavetes (Farrar, Straus and Giroux, 2001), was based
on conversations with the filmmaker in the final decades of his life.
Cassavetes died in 1989 at the age of 59. The Library of Congress is investigating
how the print came into its possession, and its Motion Picture Division
is restoring the newly discovered version of Faces, with plans to eventually
release it to the public.
AdipoGenix to collaborate with Johnson & Johnson
AdipoGenix, Inc., a Boston-based drug discovery company that was formed in 1999 by a multidisciplinary team of Boston Medical Center scientists and doctors, will collaborate with Johnson & Johnson Pharmaceutical Research and Development, LLC, to develop treatments for obesity. The companies have agreed to work together on the evaluation, validation, and development of a series of anti-obesity compounds using AdipoGenix’s propriety drug discovery process and Johnson & Johnson’s compound library resources and expertise in drug discovery and development. AdipoGenix’s mission is to discover and develop new therapeutics for the treatment of obesity and type 2 diabetes. The company’s novel use of human fat cells rather than rodent cells in the initial stages of drug discovery allows focus on very early identification of potential therapeutics that target human fat tissue. Such drugs could positively affect conditions fueled by obesity, such as diabetes, heart disease, hypertension, aging, and cancer.
CELOP part-time ESL program offered in spring 2003
BU’s Center for English Language and Orientation Programs
(CELOP) will continue its successful part-time ESL program, which was
launched in the fall of 2002, for the spring 2003 semester. The program,
designed for those from other countries who are interested in improving
their English for academic, professional, or personal reasons, surpassed
the center’s fall enrollment goals and garnered positive feedback.
Students valued the program’s convenient scheduling, small class
sizes, and quality of instruction.
“We are really enjoying the addition of part-time students to CELOP’s
programs,” says Margot Valdivia, CELOP director. “These are
people who have already established themselves in Boston -- as professionals
and students -- so they bring a different perspective to their classes.”
Spring semester begins on January 27 and runs through April 17. Tuition
is $590 for each evening course and $750 for each daytime course. For
more information or to register, visit www.bu.edu/celop/part-time or call
353-4870.
10
January 2003
Boston University
Office of University Relations